Dr. Buck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2249 State Route 86
Suite 3
Saranac Lake, NY 12983Phone+1 518-891-3845Fax+1 518-891-1236
Education & Training
- University of North Carolina HospitalsResidency, Internal Medicine/Pediatrics, 1991 - 1995
- Indiana University School of MedicineClass of 1991
Certifications & Licensure
- NY State Medical License 1995 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Publications & Presentations
PubMed
- 170 citationsFeedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.Elizabeth Buck, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin, Stuart Thomson, Mark J. Mulvihill
Cancer Research. 2008-10-15 - 100 citationsInactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to e...Elizabeth Buck, Alexandra Eyzaguirre, John D. Haley, Neil W. Gibson, Pablo Cagnoni
Molecular Cancer Therapeutics. 2006-08-01 - 194 citationsRapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumorsElizabeth Buck, Alexandra Eyzaguirre, Eric J. Brown, Filippo Petti, Siobhan McCormack
Molecular Cancer Therapeutics. 2006-11-01
Press Mentions
- Maryville Online DNP Information SessionMay 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: